According to Kiniksa Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is HK$2.63 B. In 2023 the company made a revenue of HK$2.11 B an increase over the revenue in the year 2022 that were of HK$1.72 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.